Skip to main content
Top
Published in: Malaria Journal 1/2016

Open Access 01-12-2016 | Methodology

A new tool for the chemical genetic investigation of the Plasmodium falciparum Pfnek-2 NIMA-related kinase

Authors: Deborah F. Mitcheson, Andrew R. Bottrill, Katherine Carr, Christopher R. Coxon, Celine Cano, Bernard T. Golding, Roger J. Griffin, Andrew M. Fry, Christian Doerig, Richard Bayliss, Andrew B. Tobin

Published in: Malaria Journal | Issue 1/2016

Login to get access

Abstract

Background

Examining essential biochemical pathways in Plasmodium falciparum presents serious challenges, as standard molecular techniques such as siRNA cannot be employed in this organism, and generating gene knock-outs of essential proteins requires specialized conditional approaches. In the study of protein kinases, pharmacological inhibition presents a feasible alternative option. However, as in mammalian systems, inhibitors often lack the desired selectivity. Described here is a chemical genetic approach to selectively inhibit Pfnek-2 in P. falciparum, a member of the NIMA-related kinase family that is essential for completion of the sexual development of the parasite.

Results

Introduction of a valine to cysteine mutation at position 24 in the glycine rich loop of Pfnek-2 does not affect kinase activity but confers sensitivity to the protein kinase inhibitor 4-(6-ethynyl-9H-purin-2-ylamino) benzene sulfonamide (NCL-00016066). Using a combination of in vitro kinase assays and mass spectrometry, (including phosphoproteomics) the study shows that this compound acts as an irreversible inhibitor to the mutant Pfnek2 likely through a covalent link with the introduced cysteine residue. In particular, this was shown by analysis of total protein mass using mass spectrometry which showed a shift in molecular weight of the mutant kinase in the presence of the inhibitor to be precisely equivalent to the molecular weight of NCL-00016066. A similar molecular weight shift was not observed in the wild type kinase. Importantly, this inhibitor has little activity towards the wild type Pfnek-2 and, therefore, has all the properties of an effective chemical genetic tool that could be employed to determine the cellular targets for Pfnek-2.

Conclusions

Allelic replacement of wild-type Pfnek-2 with the mutated kinase will allow for targeted inhibition of Pfnek-2 with NCL-00016066 and hence pave the way for comparative studies aimed at understanding the biological role and transmission-blocking potential of Pfnek-2.
Literature
1.
go back to reference WHO. World Malaria Report 2015. Geneva: World Health Organization; 2015:280. WHO. World Malaria Report 2015. Geneva: World Health Organization; 2015:280.
2.
go back to reference Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM. Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med. 2008;359:2619–20.CrossRefPubMed Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM. Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med. 2008;359:2619–20.CrossRefPubMed
3.
go back to reference Phyo AP, Nkhoma S, Stepniewska K, Ashley EA, Nair S, McGready R, et al. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet. 2012;379:1960–6.CrossRefPubMedPubMedCentral Phyo AP, Nkhoma S, Stepniewska K, Ashley EA, Nair S, McGready R, et al. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet. 2012;379:1960–6.CrossRefPubMedPubMedCentral
4.
go back to reference Dondorp AM, Nosten F, Poravuth Y, Das D, Phyo AP, Tarning J, et al. Artemisinin resistance in Plasmodium falciparum malaria. Drug Therapy. 2009;361:455–67. Dondorp AM, Nosten F, Poravuth Y, Das D, Phyo AP, Tarning J, et al. Artemisinin resistance in Plasmodium falciparum malaria. Drug Therapy. 2009;361:455–67.
5.
go back to reference Solyakov L, Halbert J, Alam MM, Semblat J-P, Dorin-Semblat D, Reininger L, et al. Global kinomic and phospho-proteomic analyses of the human malaria parasite Plasmodium falciparum. Nat Commun. 2011;2:565.CrossRefPubMed Solyakov L, Halbert J, Alam MM, Semblat J-P, Dorin-Semblat D, Reininger L, et al. Global kinomic and phospho-proteomic analyses of the human malaria parasite Plasmodium falciparum. Nat Commun. 2011;2:565.CrossRefPubMed
6.
go back to reference Doerig C, Billker O, Haystead T, Sharma P, Tobin AB, Waters NC. Protein kinases of malaria parasites: an update. Trends Parasitol. 2008;24:570–7.CrossRefPubMed Doerig C, Billker O, Haystead T, Sharma P, Tobin AB, Waters NC. Protein kinases of malaria parasites: an update. Trends Parasitol. 2008;24:570–7.CrossRefPubMed
7.
go back to reference Zuccotto F, Ardini E, Casale E, Angiolini M. Through the “gatekeeper door”: exploiting the active kinase conformation. J Med Chem. 2010;53:2681–94.CrossRefPubMed Zuccotto F, Ardini E, Casale E, Angiolini M. Through the “gatekeeper door”: exploiting the active kinase conformation. J Med Chem. 2010;53:2681–94.CrossRefPubMed
8.
go back to reference Reininger L, Billker O, Tewari R, Mukhopadhyay A, Fennell C, Dorin-Semblat D, et al. A NIMA-related protein kinase is essential for completion of the sexual cycle of malaria parasites. J Biol Chem. 2005;280:31957–64.CrossRefPubMed Reininger L, Billker O, Tewari R, Mukhopadhyay A, Fennell C, Dorin-Semblat D, et al. A NIMA-related protein kinase is essential for completion of the sexual cycle of malaria parasites. J Biol Chem. 2005;280:31957–64.CrossRefPubMed
9.
go back to reference Reininger L, Tewari R, Fennell C, Holland Z, Goldring D, Ranford-Cartwright L, et al. An essential role for the Plasmodium Nek-2 Nima-related protein kinase in the sexual development of malaria parasites. J Biol Chem. 2009;284:20858–68.CrossRefPubMedPubMedCentral Reininger L, Tewari R, Fennell C, Holland Z, Goldring D, Ranford-Cartwright L, et al. An essential role for the Plasmodium Nek-2 Nima-related protein kinase in the sexual development of malaria parasites. J Biol Chem. 2009;284:20858–68.CrossRefPubMedPubMedCentral
10.
go back to reference Dorin-Semblat D, Schmitt S, Semblat JP, Sicard A, Reininger L, Goldring D, et al. Plasmodium falciparum NIMA-related kinase Pfnek-1: sex specificity and assessment of essentiality for the erythrocytic asexual cycle. Microbiology. 2011;157:2785–94.CrossRefPubMedPubMedCentral Dorin-Semblat D, Schmitt S, Semblat JP, Sicard A, Reininger L, Goldring D, et al. Plasmodium falciparum NIMA-related kinase Pfnek-1: sex specificity and assessment of essentiality for the erythrocytic asexual cycle. Microbiology. 2011;157:2785–94.CrossRefPubMedPubMedCentral
11.
go back to reference Reininger L, Garcia M, Tomlins A, Muller S, Doerig C. The Plasmodium falciparum, Nima-related kinase Pfnek-4: a marker for asexual parasites committed to sexual differentiation. Malar J. 2012;11:250.CrossRefPubMedPubMedCentral Reininger L, Garcia M, Tomlins A, Muller S, Doerig C. The Plasmodium falciparum, Nima-related kinase Pfnek-4: a marker for asexual parasites committed to sexual differentiation. Malar J. 2012;11:250.CrossRefPubMedPubMedCentral
12.
go back to reference Dorin D, Le Roch K, Sallicandro P, Alano P, Parzy D, Poullet P, et al. Pfnek-1, a NIMA-related kinase from the human malaria parasite Plasmodium falciparum. Eur J Biochem. 2001;268:2600–8.CrossRefPubMed Dorin D, Le Roch K, Sallicandro P, Alano P, Parzy D, Poullet P, et al. Pfnek-1, a NIMA-related kinase from the human malaria parasite Plasmodium falciparum. Eur J Biochem. 2001;268:2600–8.CrossRefPubMed
14.
go back to reference Hayward DG, Newbatt Y, Pickard L, Byrne E, Mao G, Burns S, et al. Identification by high-throughput screening of viridin analogs as biochemical and cell-based inhibitors of the cell cycle-regulated nek2 kinase. J Biomol Screen. 2010;15:918–27.CrossRefPubMedPubMedCentral Hayward DG, Newbatt Y, Pickard L, Byrne E, Mao G, Burns S, et al. Identification by high-throughput screening of viridin analogs as biochemical and cell-based inhibitors of the cell cycle-regulated nek2 kinase. J Biomol Screen. 2010;15:918–27.CrossRefPubMedPubMedCentral
15.
go back to reference Hayward DG, Clarke RB, Faragher AJ, Pillai MR, Hagan IM, Fry AM. The centrosomal kinase Nek2 displays elevated levels of protein expression in human breast cancer. Cancer Res. 2004;64:7370–6.CrossRefPubMed Hayward DG, Clarke RB, Faragher AJ, Pillai MR, Hagan IM, Fry AM. The centrosomal kinase Nek2 displays elevated levels of protein expression in human breast cancer. Cancer Res. 2004;64:7370–6.CrossRefPubMed
16.
go back to reference Hayward DG, Fry AM. Nek2 kinase in chromosome instability and cancer. Cancer Lett. 2006;237:155–66.CrossRefPubMed Hayward DG, Fry AM. Nek2 kinase in chromosome instability and cancer. Cancer Lett. 2006;237:155–66.CrossRefPubMed
18.
go back to reference Kokuryo T, Senga T, Yokoyama Y, Nagino M, Nimura Y, Hamaguchi M. Nek2 as an effective target for inhibition of tumorigenic growth and peritoneal dissemination of cholangiocarcinoma. Cancer Res. 2007;67:9637–42.CrossRefPubMed Kokuryo T, Senga T, Yokoyama Y, Nagino M, Nimura Y, Hamaguchi M. Nek2 as an effective target for inhibition of tumorigenic growth and peritoneal dissemination of cholangiocarcinoma. Cancer Res. 2007;67:9637–42.CrossRefPubMed
19.
go back to reference Tsunoda N, Kokuryo T, Oda K, Senga T, Yokoyama Y, Nagino M, et al. Nek2 as a novel molecular target for the treatment of breast carcinoma. Cancer Sci. 2009;100:111–6.CrossRefPubMed Tsunoda N, Kokuryo T, Oda K, Senga T, Yokoyama Y, Nagino M, et al. Nek2 as a novel molecular target for the treatment of breast carcinoma. Cancer Sci. 2009;100:111–6.CrossRefPubMed
20.
go back to reference Whelligan DK, Solanki S, Taylor D, Thomson DW, Cheung KMJ, Boxall K, et al. Aminopyrazine inhibitors binding to an unusual inactive conformation of the mitotic kinase Nek2: SAR and structural characterization. J Med Chem. 2010;53:7682–98.CrossRefPubMedPubMedCentral Whelligan DK, Solanki S, Taylor D, Thomson DW, Cheung KMJ, Boxall K, et al. Aminopyrazine inhibitors binding to an unusual inactive conformation of the mitotic kinase Nek2: SAR and structural characterization. J Med Chem. 2010;53:7682–98.CrossRefPubMedPubMedCentral
21.
go back to reference Westwood I, Cheary DM, Baxter JE, Richards MW, van Montfort RLM, Fry AM, et al. Insights into the Conformational Variability and Regulation of Human Nek2 Kinase. J Mol Biol. 2009;386:476–85.CrossRefPubMedPubMedCentral Westwood I, Cheary DM, Baxter JE, Richards MW, van Montfort RLM, Fry AM, et al. Insights into the Conformational Variability and Regulation of Human Nek2 Kinase. J Mol Biol. 2009;386:476–85.CrossRefPubMedPubMedCentral
22.
go back to reference Solanki S, Innocenti P, Mas-Droux C, Boxall K, Barillari C, Van Montfort RLM, et al. Benzimidazole inhibitors induce a DFG-out conformation of never in mitosis gene a-related kinase 2 (Nek2) without binding to the back pocket and reveal a nonlinear structure-activity relationship. J Med Chem. 2011;54:1626–39.CrossRefPubMed Solanki S, Innocenti P, Mas-Droux C, Boxall K, Barillari C, Van Montfort RLM, et al. Benzimidazole inhibitors induce a DFG-out conformation of never in mitosis gene a-related kinase 2 (Nek2) without binding to the back pocket and reveal a nonlinear structure-activity relationship. J Med Chem. 2011;54:1626–39.CrossRefPubMed
23.
go back to reference Richards MW, O’Regan L, Mas-Droux C, Blot JMY, Cheung J, Hoelder S, et al. An autoinhibitory tyrosine motif in the cell-cycle-regulated Nek7 kinase is released through binding of Nek9. Mol Cell. 2009;36:560–70.CrossRefPubMedPubMedCentral Richards MW, O’Regan L, Mas-Droux C, Blot JMY, Cheung J, Hoelder S, et al. An autoinhibitory tyrosine motif in the cell-cycle-regulated Nek7 kinase is released through binding of Nek9. Mol Cell. 2009;36:560–70.CrossRefPubMedPubMedCentral
24.
go back to reference Lebraud H, Coxon CR, Archard VS, Bawn CM, Carbain B, Matheson CJ, et al. Model system for irreversible inhibition of Nek2: thiol addition to ethynylpurines and related substituted heterocycles. Org Biomol Chem. 2013;12:141–8.CrossRefPubMed Lebraud H, Coxon CR, Archard VS, Bawn CM, Carbain B, Matheson CJ, et al. Model system for irreversible inhibition of Nek2: thiol addition to ethynylpurines and related substituted heterocycles. Org Biomol Chem. 2013;12:141–8.CrossRefPubMed
25.
26.
go back to reference Lambros C, Vanderberg JP. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol. 1979;65:418–20.CrossRefPubMed Lambros C, Vanderberg JP. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol. 1979;65:418–20.CrossRefPubMed
27.
go back to reference Winkler R. ESIprot: a universal tool for charge state determination and molecular weight calculation of proteins from electrospray ionization mass spectrometry data. Rapid Commun Mass Spectrom. 2010;24:285–94.CrossRefPubMed Winkler R. ESIprot: a universal tool for charge state determination and molecular weight calculation of proteins from electrospray ionization mass spectrometry data. Rapid Commun Mass Spectrom. 2010;24:285–94.CrossRefPubMed
28.
go back to reference Alam MM, Solyakov L, Bottrill AR, Flueck C, Siddiqui FA, Singh S, et al. Phosphoproteomics reveals malaria parasite Protein Kinase G as a signalling hub regulating egress and invasion. Nat. Commun. 2015;6:7285.CrossRefPubMedPubMedCentral Alam MM, Solyakov L, Bottrill AR, Flueck C, Siddiqui FA, Singh S, et al. Phosphoproteomics reveals malaria parasite Protein Kinase G as a signalling hub regulating egress and invasion. Nat. Commun. 2015;6:7285.CrossRefPubMedPubMedCentral
29.
go back to reference Rellos P, Ivins FJ, Baxter JE, Pike A, Nott TJ, Parkinson DM, et al. Structure and regulation of the human Nek2 centrosomal kinase. J Biol Chem. 2007;282:6833–42.CrossRefPubMed Rellos P, Ivins FJ, Baxter JE, Pike A, Nott TJ, Parkinson DM, et al. Structure and regulation of the human Nek2 centrosomal kinase. J Biol Chem. 2007;282:6833–42.CrossRefPubMed
Metadata
Title
A new tool for the chemical genetic investigation of the Plasmodium falciparum Pfnek-2 NIMA-related kinase
Authors
Deborah F. Mitcheson
Andrew R. Bottrill
Katherine Carr
Christopher R. Coxon
Celine Cano
Bernard T. Golding
Roger J. Griffin
Andrew M. Fry
Christian Doerig
Richard Bayliss
Andrew B. Tobin
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Malaria Journal / Issue 1/2016
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/s12936-016-1580-3

Other articles of this Issue 1/2016

Malaria Journal 1/2016 Go to the issue